Int. J. Mol. Sci., 2023 · DOI: 10.3390/ijms241813938 · Published: September 11, 2023
Spinal cord injury (SCI) is a devastating event that results in a wide range of physical impairments and disabilities. Recent studies have shown the utility of zebrafish as a model of neural regeneration following SCIs, including the proliferation and migration of various cell types and the involvement of various progenitor cells. More in-depth studies are needed to fully understand the neural regeneration mechanisms, proteins, and signaling pathways involved in the complex interactions between the SCI microenvironment and transplanted cells in non-mammals, particularly in the zebrafish model, which could, in turn, lead to new therapeutic approaches to treat SCIs in humans and other mammals.
Candidate genes and pathways identified in zebrafish can serve as therapeutic targets for treating CNS injuries.
Zebrafish models can be used for high-throughput drug screening to identify compounds that promote neural regeneration.
Findings from zebrafish studies can inform the development of novel therapeutic strategies for mammalian SCI treatment.